 | 4N3 | Name: | N-octanoyl-D-valine | Formula: | C13 H25 N O3 | SMILES: | N(C(C(C)C)C(=O)O)C(=O)CCCCCCC | InChi: | InChI=1S/C13H25NO3/c1-4-5-6-7-8-9-11(15)14-12(10(2)3)13(16)17/h10,12H,4-9H2,1-3H3,(H,14,15)(H,16,17)/t12-/m1/s1 | Definition date: | 2016-05-23 | Last modified: | 2024-09-27 | Release date: | 2016-09-28 | Identifier: | N-octanoyl-D-valine |
|
 | EI4 | Name: | Enduracididine | Formula: | C6 H12 N4 O2 | SMILES: | N[CH](C[CH]1CNC(=N)N1)C(O)=O | InChi: | InChI=1S/C6H12N4O2/c7-4(5(11)12)1-3-2-9-6(8)10-3/h3-4H,1-2,7H2,(H,11,12)(H3,8,9,10)/t3-,4-/m0/s1 | Definition date: | 2022-01-05 | Last modified: | 2024-09-27 | Release date: | 2022-08-03 | Identifier: | (2~{S})-2-azanyl-3-[(4~{S})-2-azanylideneimidazolidin-4-yl]propanoic acid |
|
 | ELY | Name: | N~6~,N~6~-diethyl-L-lysine | Formula: | C10 H22 N2 O2 | SMILES: | C(=O)(C(N)CCCCN(CC)CC)O | InChi: | InChI=1S/C10H22N2O2/c1-3-12(4-2)8-6-5-7-9(11)10(13)14/h9H,3-8,11H2,1-2H3,(H,13,14)/t9-/m0/s1 | Synonyms: | (2S)-2-azanyl-6-(diethylamino)hexanoic acid | Definition date: | 2011-03-25 | Last modified: | 2024-09-27 | Identifier: | N~6~,N~6~-diethyl-L-lysine |
|
 | EP0 | Name: | N-[(3R)-4-ethoxy-3-hydroxy-4-oxobutanoyl]-L-isoleucyl-L-proline | Formula: | C17 H28 N2 O7 | SMILES: | O=C(O)C1N(C(=O)C(NC(=O)CC(O)C(=O)OCC)C(C)CC)CCC1 | InChi: | InChI=1S/C17H28N2O7/c1-4-10(3)14(15(22)19-8-6-7-11(19)16(23)24)18-13(21)9-12(20)17(25)26-5-2/h10-12,14,20H,4-9H2,1-3H3,(H,18,21)(H,23,24)/t10-,11-,12+,14-/m0/s1 | Synonyms: | epoxy succinyl inhibitor | Definition date: | 2008-03-25 | Last modified: | 2024-09-27 | Identifier: | N-[(3R)-4-ethoxy-3-hydroxy-4-oxobutanoyl]-L-isoleucyl-L-proline |
|
 | ESB | Name: | 3-[(3E)-3-(ETHYLIMINO)-4-HYDROXY-6-OXOCYCLOHEXA-1,4-DIEN-1-YL]-L-ALANINE | Formula: | C11 H14 N2 O4 | SMILES: | O=C1C=C(O)/C(=N/CC)C=C1CC(C(=O)O)N | InChi: | InChI=1S/C11H14N2O4/c1-2-13-8-4-6(3-7(12)11(16)17)9(14)5-10(8)15/h4-5,7,15H,2-3,12H2,1H3,(H,16,17)/b13-8+/t7-/m0/s1 | Definition date: | 2008-04-03 | Last modified: | 2024-09-27 | Identifier: | 3-[(3E)-3-(ethylimino)-4-hydroxy-6-oxocyclohexa-1,4-dien-1-yl]-L-alanine |
|
 | EU0 | Name: | 1-[(2~{S})-3-methyl-1-oxidanylidene-butan-2-yl]guanidine | Formula: | C6 H14 N3 O2 | SMILES: | CC(C)[CH](NC(N)=[NH2+])C(O)=O | InChi: | InChI=1S/C6H13N3O2/c1-3(2)4(5(10)11)9-6(7)8/h3-4H,1-2H3,(H,10,11)(H4,7,8,9)/p+1/t4-/m0/s1 | Definition date: | 2022-01-13 | Last modified: | 2024-09-27 | Release date: | 2023-05-10 | Identifier: | [azanyl-[[(2~{S})-3-methyl-1-oxidanyl-1-oxidanylidene-butan-2-yl]amino]methylidene]azanium |
|
 | HOV | Name: | ethyl (4R)-4-[[(2S,3R)-1-[(2S)-3-methyl-2-[(5-methyl-1,2-oxazol-3-yl)carbonylamino]butanoyl]-3-phenyl-pyrrolidin-2-yl]carbonylamino]-5-[(3S)-2-oxidanylidenepyrrolidin-3-yl]pentanoate | Formula: | C32 H43 N5 O7 | SMILES: | CCOC(=O)CCC(NC(=O)C1N(CCC1c2ccccc2)C(=O)C(NC(=O)c3noc(c3)C)C(C)C)CC4CCNC4=O | InChi: | InChI=1S/C32H43N5O7/c1-5-43-26(38)12-11-23(18-22-13-15-33-29(22)39)34-31(41)28-24(21-9-7-6-8-10-21)14-16-37(28)32(42)27(19(2)3)35-30(40)25-17-20(4)44-36-25/h6-10,17,19,22-24,27-28H,5,11-16,18H2,1-4H3,(H,33,39)(H,34,41)(H,35,40)/t22-,23+,24+,27-,28-/m0/s1 | Definition date: | 2016-02-25 | Last modified: | 2024-09-27 | Release date: | 2016-06-22 | Identifier: | N-(5-methyl-1,2-oxazole-3-carbonyl)-L-valyl-(3R)-N-{(2R)-5-ethoxy-5-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]pentan-2-yl}-3-phenyl-L-prolinamide |
|
 | HOX | Name: | 4-amino-L-phenylalanine | Formula: | C9 H12 N2 O2 | SMILES: | O=C(O)C(N)Cc1ccc(N)cc1 | InChi: | InChI=1S/C9H12N2O2/c10-7-3-1-6(2-4-7)5-8(11)9(12)13/h1-4,8H,5,10-11H2,(H,12,13)/t8-/m0/s1 | Definition date: | 2009-08-25 | Last modified: | 2024-09-27 | Identifier: | 4-amino-L-phenylalanine |
|
 | HR7 | Name: | (3S)-3-amino-6-[(diaminomethylidene)amino]hexanoic acid | Formula: | C7 H16 N4 O2 | SMILES: | O=C(O)CC(N)CCC/N=C(N)N | InChi: | InChI=1S/C7H16N4O2/c8-5(4-6(12)13)2-1-3-11-7(9)10/h5H,1-4,8H2,(H,12,13)(H4,9,10,11) | Synonyms: | BETA-HOMOARGININE | Definition date: | 2011-05-18 | Last modified: | 2024-09-27 | Identifier: | (3S)-3-amino-6-[(diaminomethylidene)amino]hexanoic acid |
|
 | HT0 | Name: | (4R,5R)-5-(4-hydroxyphenyl)-2-oxo-1,3-oxazolidine-4-carboxylic acid | Formula: | C10 H9 N O5 | SMILES: | O=C(O)C1NC(=O)OC1c1ccc(O)cc1 | InChi: | InChI=1S/C10H9NO5/c12-6-3-1-5(2-4-6)8-7(9(13)14)11-10(15)16-8/h1-4,7-8,12H,(H,11,15)(H,13,14)/t7-,8-/m1/s1 | Definition date: | 2021-03-10 | Last modified: | 2024-09-27 | Release date: | 2022-12-07 | Identifier: | (4R,5R)-5-(4-hydroxyphenyl)-2-oxo-1,3-oxazolidine-4-carboxylic acid |
|
 | HTR | Name: | BETA-HYDROXYTRYPTOPHANE | Formula: | C11 H12 N2 O3 | SMILES: | O=C(O)C(N)C(O)c2c1ccccc1nc2 | InChi: | InChI=1S/C11H12N2O3/c12-9(11(15)16)10(14)7-5-13-8-4-2-1-3-6(7)8/h1-5,9-10,13-14H,12H2,(H,15,16)/t9-,10-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | (betaS)-beta-hydroxy-L-tryptophan |
|
 | HTY | Name: | (betaR)-beta-hydroxy-D-tyrosine | Formula: | C9 H11 N O4 | SMILES: | O=C(O)C(N)C(O)c1ccc(O)cc1 | InChi: | InChI=1S/C9H11NO4/c10-7(9(13)14)8(12)5-1-3-6(11)4-2-5/h1-4,7-8,11-12H,10H2,(H,13,14)/t7-,8-/m1/s1 | Definition date: | 2002-09-02 | Last modified: | 2024-09-27 | Identifier: | (betaR)-beta-hydroxy-D-tyrosine |
|
 | HY3 | Name: | 3-HYDROXYPROLINE | Formula: | C5 H9 N O3 | SMILES: | O=C(O)C1NCCC1O | InChi: | InChI=1S/C5H9NO3/c7-3-1-2-6-4(3)5(8)9/h3-4,6-7H,1-2H2,(H,8,9)/t3-,4-/m0/s1 | Synonyms: | (2S,3S)-3-hydroxypyrrolidine-2-carboxylic acid | Definition date: | 2006-03-22 | Last modified: | 2024-09-27 | Identifier: | (3S)-3-hydroxy-L-proline |
|
 | HZP | Name: | (4S)-4-hydroxy-L-proline | Formula: | C5 H9 N O3 | SMILES: | O=C(O)C1NCC(O)C1 | InChi: | InChI=1S/C5H9NO3/c7-3-1-4(5(8)9)6-2-3/h3-4,6-7H,1-2H2,(H,8,9)/t3-,4-/m0/s1 | Definition date: | 2009-04-16 | Last modified: | 2024-09-27 | Identifier: | (4S)-4-hydroxy-L-proline |
|
 | 6OB | Name: | (8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid | Formula: | C18 H30 O4 | SMILES: | O=C(O)CCCCC(=O)C/C=C/C(O)CC=C/CCCCC | InChi: | InChI=1S/C18H30O4/c1-2-3-4-5-6-7-11-16(19)13-10-14-17(20)12-8-9-15-18(21)22/h6-7,10,13,16,19H,2-5,8-9,11-12,14-15H2,1H3,(H,21,22)/b7-6-,13-10+/t16-/m0/s1 | Definition date: | 2008-06-02 | Last modified: | 2024-09-27 | Identifier: | (8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid |
|
 | 6OY | Name: | ethyl (4R)-4-[[(2S,4S)-1-[(2S)-3-methyl-2-[(5-methyl-1,2-oxazol-3-yl)carbonylamino]butanoyl]-4-phenyl-pyrrolidin-2-yl]carbonylamino]-5-[(3S)-2-oxidanylidenepyrrolidin-3-yl]pentanoate | Formula: | C32 H43 N5 O7 | SMILES: | CCOC(=O)CCC(NC(=O)C1N(CC(C1)c2ccccc2)C(=O)C(NC(=O)c3noc(c3)C)C(C)C)CC4CCNC4=O | InChi: | InChI=1S/C32H43N5O7/c1-5-43-27(38)12-11-24(16-22-13-14-33-29(22)39)34-31(41)26-17-23(21-9-7-6-8-10-21)18-37(26)32(42)28(19(2)3)35-30(40)25-15-20(4)44-36-25/h6-10,15,19,22-24,26,28H,5,11-14,16-18H2,1-4H3,(H,33,39)(H,34,41)(H,35,40)/t22-,23+,24+,26-,28-/m0/s1 | Definition date: | 2016-02-25 | Last modified: | 2024-09-27 | Release date: | 2016-06-22 | Identifier: | N-(5-methyl-1,2-oxazole-3-carbonyl)-L-valyl-(4S)-N-{(2R)-5-ethoxy-5-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]pentan-2-yl}-4-phenyl-L-prolinamide |
|
 | OMX | Name: | (betaR)-beta-hydroxy-L-Tyrosine | Formula: | C9 H11 N O4 | SMILES: | O=C(O)C(N)C(O)c1ccc(O)cc1 | InChi: | InChI=1S/C9H11NO4/c10-7(9(13)14)8(12)5-1-3-6(11)4-2-5/h1-4,7-8,11-12H,10H2,(H,13,14)/t7-,8+/m0/s1 | Definition date: | 2010-08-10 | Last modified: | 2024-09-27 | Identifier: | (betaR)-beta-hydroxy-L-tyrosine |
|
 | OMY | Name: | (betaR)-3-chloro-beta-hydroxy-L-tyrosine | Formula: | C9 H10 Cl N O4 | SMILES: | Clc1cc(ccc1O)C(O)C(C(=O)O)N | InChi: | InChI=1S/C9H10ClNO4/c10-5-3-4(1-2-6(5)12)8(13)7(11)9(14)15/h1-3,7-8,12-13H,11H2,(H,14,15)/t7-,8+/m0/s1 | Definition date: | 2009-03-27 | Last modified: | 2024-09-27 | Identifier: | (betaR)-3-chloro-beta-hydroxy-L-tyrosine |
|
 | OMZ | Name: | (betaR)-3-CHLORO-BETA-HYDROXY-D-TYROSINE | Formula: | C9 H10 Cl N O4 | SMILES: | Clc1cc(ccc1O)C(O)C(C(=O)O)N | InChi: | InChI=1S/C9H10ClNO4/c10-5-3-4(1-2-6(5)12)8(13)7(11)9(14)15/h1-3,7-8,12-13H,11H2,(H,14,15)/t7-,8-/m1/s1 | Definition date: | 2010-08-06 | Last modified: | 2024-09-27 | Identifier: | (betaR)-3-chloro-beta-hydroxy-D-tyrosine |
|
 | ONH | Name: | N~5~-hydroxy-L-ornithine | Formula: | C5 H12 N2 O3 | SMILES: | O=C(O)C(N)CCCNO | InChi: | InChI=1S/C5H12N2O3/c6-4(5(8)9)2-1-3-7-10/h4,7,10H,1-3,6H2,(H,8,9)/t4-/m0/s1 | Definition date: | 2011-06-02 | Last modified: | 2024-09-27 | Identifier: | N~5~-hydroxy-L-ornithine |
|
 | OTH | Name: | N,O-dimethyl-L-threonine | Formula: | C6 H13 N O3 | SMILES: | O=C(O)C(NC)C(OC)C | InChi: | InChI=1S/C6H13NO3/c1-4(10-3)5(7-2)6(8)9/h4-5,7H,1-3H3,(H,8,9)/t4-,5+/m1/s1 | Definition date: | 2010-05-20 | Last modified: | 2024-09-27 | Identifier: | N,O-dimethyl-L-threonine |
|
 | OUI | Name: | [(2~{S},3~{S})-2-azanyl-3-methyl-pentyl]carbamic acid | Formula: | C7 H16 N2 O2 | SMILES: | CC[CH](C)[CH](N)CNC(O)=O | InChi: | InChI=1S/C7H16N2O2/c1-3-5(2)6(8)4-9-7(10)11/h5-6,9H,3-4,8H2,1-2H3,(H,10,11)/t5-,6+/m0/s1 | Definition date: | 2017-02-10 | Last modified: | 2024-09-27 | Release date: | 2017-04-12 | Identifier: | [(2~{S},3~{S})-2-azanyl-3-methyl-pentyl]carbamic acid |
|
 | 7BB | Name: | trans-4-({[(E)-1-amino-2-sulfanylethenyl](4-carboxybutyl)carbamoyl}oxy)cyclohexanecarboxylic acid | Formula: | C15 H24 N2 O6 S | SMILES: | O=C(OC1CCC(C(=O)O)CC1)N(C(=CS)N)CCCCC(=O)O | InChi: | InChI=1S/C15H24N2O6S/c16-12(9-24)17(8-2-1-3-13(18)19)15(22)23-11-6-4-10(5-7-11)14(20)21/h9-11,24H,1-8,16H2,(H,18,19)(H,20,21)/b12-9+/t10-,11- | Definition date: | 2012-01-04 | Last modified: | 2024-09-27 | Identifier: | trans-4-({[(E)-1-amino-2-sulfanylethenyl](4-carboxybutyl)carbamoyl}oxy)cyclohexanecarboxylic acid |
|
 | 7EP | Name: | (2R,4S)-2-[(1R)-1-{[(2,6-dimethoxyphenyl)carbonyl]amino}-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid | Formula: | C17 H22 N2 O6 S | SMILES: | O=C(NC(C=O)C1SC(C(N1)C(=O)O)(C)C)c2c(OC)cccc2OC | InChi: | InChI=1S/C17H22N2O6S/c1-17(2)13(16(22)23)19-15(26-17)9(8-20)18-14(21)12-10(24-3)6-5-7-11(12)25-4/h5-9,13,15,19H,1-4H3,(H,18,21)(H,22,23)/t9-,13+,15-/m1/s1 | Synonyms: | methicillin, bound form | Definition date: | 2010-06-28 | Last modified: | 2024-09-27 | Identifier: | (2R,4S)-2-{(1R)-1-[(2,6-dimethoxybenzoyl)amino]-2-oxoethyl}-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid |
|
 | DNG | Name: | N-FORMYL-D-NORLEUCINE | Formula: | C7 H13 N O3 | SMILES: | O=CNC(C(=O)O)CCCC | InChi: | InChI=1S/C7H13NO3/c1-2-3-4-6(7(10)11)8-5-9/h5-6H,2-4H2,1H3,(H,8,9)(H,10,11)/t6-/m1/s1 | Definition date: | 2004-01-27 | Last modified: | 2024-09-27 | Identifier: | N-formyl-D-norleucine |
|